Browse by:
Industry

Community health firm expands into Worcester

Sam Bonacci |

Civitas Solutions of Boston has acquired Worcester's Renaissance Adult Day Care center in a three-center deal as the firm looks to grow in Central Massachusetts.

Health New England launches new brand, logo

Sam Bonacci |

Health New England has rebranded itself with the new tagline of “where you matter,” complete with a new logo and website.

Boston Scientific device receives Medicare and Medicaid clearance

Sam Bonacci |

A device built by Marlborough's Boston Scientific has just received clearance from the Centers for Medicare and Medicaid Services (CMS) to be used as a non-pharmacological treatment option for stroke...

Spectrum Health expands prison partnership

Sam Bonacci |

Spectrum Health Systems will soon receive federal funding through a partnership with the Massachusetts Department of Correction (DOC) to combat the ongoing opioid abuse crisis.

Front Street towers renamed Mercantile Center; interior construction underway

Sam Bonacci |

The Front Street office towers have been renamed Mercantile Center as their owners pursue an aggressive timeline for interior renovations.

State seeks Medicaid waiver renegotiation

STATE HOUSE NEWS SERVICE |

With billions of dollars on the line, Gov. Charlie Baker hopes to renegotiate a federal Medicaid waiver with the Obama administration by this summer, he said Tuesday.

Baker property measure stirs debate

STATE HOUSE NEWS SERVICE |

The lieutenant governor, Baker administration officials and municipal administrators on Tuesday testified in support of reforms that they said would give municipal government officials in...

MBTA ad revenues boosted by digital marketing

STATE HOUSE NEWS SERVICE |

Capital One, Coca Cola and JetBlue are among the companies that have helped the MBTA far outpace its ad revenue from a year ago.

Mount Wachusett's president Asquino to retire

Sam Bonacci |

Mount Wachusett Community College President Daniel Asquino announced that he will step down from his position in 2017.

Ocata Therapeutics purchased for $384M

Sam Bonacci |

Tokyo's Astellas Pharma Inc. has completed its $384 million purchase of Marlborough's Ocata Therapeutics.

ADVERTISEMENTS
Copyright 2016 New England Business Media